McClellan outlines FDA efforts at BIO 2003

被引：0

|

作者：

Jarvis, Lisa

机构：

来源：

Chemical Market Reporter | 2003年 / 263卷 / 26期

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

收藏

相关论文

共 50 条

[31] FDA boosts efforts to improve safe use of pharmaceuticals
Wechsler, J
FORMULARY, 2001, 36 (04) : 308 - 309
[32] FDA enforcement efforts and drug approvals trend upward
Peters, Rita
BIOPHARM INTERNATIONAL, 2018, 31 (03) : 6 - 6
[33] FDA Reform: Setting the Stage for Efforts to Reform the Agency
Kenneth I. Kaitin
Drug information journal : DIJ / Drug Information Association, 1997, 31 (1): : 27 - 33
[34] FDA Commissioner Outlines New Plan to Increase Biosimilars by Balancing Innovation and Competition
Koutnik-Fotopoulos, Eileen
AMERICAN HEALTH AND DRUG BENEFITS, 2018, 11 (08): : 427 - 428
[35] Keynote speakers at Bio 2003
Howard, B
AMERICAN LABORATORY, 2003, 35 (18) : 6 - +
[36] Current research efforts at FDA on the problem of food adulteration.
Ziobro, GC
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1996, 212 : 3 - AGFD
[37] FDA's Efforts to Tame the "Wild West'' of Regenerative Medicine
Holman, Christopher M.
BIOTECHNOLOGY LAW REPORT, 2017, 36 (05) : 217 - 221
[38] OSHA renews enforcement efforts - EPA outlines Food Quality Protection Act implementation
Hattal, AM
CHEMICAL PROCESSING, 1997, 60 (05): : 12 - 12
[39] VACCINES FDA outlines how to adapt COVID-19 vaccines to virus variants
Mullard, Asher
CHEMICAL & ENGINEERING NEWS, 2021, 99 (07) : 17 - 17
[40] Bio-based carbon fibers - Efforts and prospects
Fink, Hans-Peter
Lehmann, André
Ganster, Johannes
Chemical Fibers International, 2013, 63 (01): : 29 - 30

← 1 2 3 4 5 →